The PREDICTFTD consortium successfully concluded its general assembly meeting, held from 26 to 27 March in Desenzano del Garda, Italy. The meeting brought together the project partners in person and online.
The meeting officially opened on 26 March with a warm welcome from the project coordinator, Harro Seelaar (Eras-mus MC), together with Gianluigi Zanusso (University of Verona), who kindly hosted and organised the meeting.
The meeting then focused on project partners providing updates across the consortium, i.e. ongoing work packages focused on biomarkers, artificial intelligence modelling, olfactory swab sampling, public involvement, and a really interesting demo of how data systems are coming together. We also had important discussions on the regulatory roadmap and ethics. A highlight of the first day of the meet-ing was the keynote lecture delivered by Dr Sergi Borrego (Hospital Clínic de Barcelona, Spain), which provided gen-eral information about Frontotemporal dementia (FTD) and its subtypes, as well as the latest developments in FTD.
The general assembly meeting enabled fruitful exchanges between project partners, strengthening collaboration, re-viewing the progress made so far and the next steps to-wards an earlier and more accurate diagnosis of FTD.
The PREDICTFTD project was launched in December 2024, funded by the EU’s Horizon Europe programme for a period of 4.5 years. The project, which includes partners from 8 countries, is developing biomarkers and tools to advance the diagnosis of FTD, aiming to reduce the time it takes to obtain an accurate, biological diagnosis of the condition.
Learn more about PREDICTFTD:
https://www.predictftd.eu/
